Merck & Co.’s RSV Antibody Approved In US In Time To Compete With Blockbuster Beyfortus

CDC Sign-Off Expected In June, Orders To Follow In July

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.